Recherche
-
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
(Nature Communications. vol. 12, n° 1, pp. 5215, 2021-09-01)Article de revueLibre accès -
Estimating the population effectiveness of interventions against COVID-19 in France: A modelling study
(Epidemics. vol. 46, pp. 100744, 2024-03-01)Article de revueLibre accès -
Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola
(NPJ vaccines. vol. 8, n° 1, pp. 174, 2023-11-08)Article de revueLibre accès -
Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
(eLife. vol. 11, pp. e75427, 2022-07-08)Article de revueLibre accès -
Barrier Gesture Relaxation during Vaccination Campaign in France: Modelling Impact of Waning Immunity
(COVID. vol. 1, n° 2, pp. 472-488, 2021-10-09)Article de revueLibre accès -
Impact of non-pharmaceutical interventions, weather, vaccination, and variants on COVID-19 transmission across departments in France: a modelling study
Document de travail - Pré-publicationLibre accès -
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
(EBioMedicine. vol. 80, 2022-06)Article de revueLibre accès -
Parameter estimation in nonlinear mixed effect models based on ordinary differential equations: An optimal control approach
(Computational Statistics, 2023-10-14)Article de revueLibre accès